Jentashapir Journal of Health Research

Published by: Kowsar

Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests

Yaghoob Farbood 1 , * , Seyyed Mohammad Taghi Mansouri 2 , Seyyed Mostafa Ahmadian 1 , Seyyad Ali Mard 1 and Alireza Sarkaki 1
Authors Information
1 Department of Physiology, Physiology Research Center, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacology, Physiology Research Center, Medical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jentashapir Journal of Health Research: December 01, 2015, 6 (6); e29311
  • Published Online: December 14, 2015
  • Article Type: Research Article
  • Received: April 17, 2015
  • Revised: June 22, 2015
  • Accepted: July 13, 2015
  • DOI: 10.17795/jjhr-29311

To Cite: Farbood Y, Mansouri S M T, Ahmadian S M, Mard S A, Sarkaki A. Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests, Jentashapir J Health Res. 2015 ; 6(6):e29311. doi: 10.17795/jjhr-29311.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Pollack MH. New advances in the management of anxiety disorders. Psychopharmacol Bull. 2002; 36(4): 79-94[PubMed]
  • 2. Shorter E, Tyrer P. Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease. BMJ. 2003; 327(7407): 158-60[DOI][PubMed]
  • 3. Kunovac JL, Stahl SM. Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am. 1995; 18(4): 895-909[PubMed]
  • 4. Girish C, Raj V, Arya J, Balakrishnan S. Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice. Eur J Pharmacol. 2013; 710(1-3): 49-58[DOI][PubMed]
  • 5. Medina JH, Peña C, Levi de Stein M, Wolfman C, Paladini AC. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun. 1989; 165(2): 547-53[DOI]
  • 6. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002; 50(7): 2200-6[PubMed]
  • 7. Kaur S, Grover IS, Kumar S. Antimutagenic potential of ellagic acid isolated from Terminalia arjuna. Indian J Exp Biol. 1997; 35(5): 478-82[PubMed]
  • 8. Makena PS, Chung KT. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem Toxicol. 2007; 45(10): 1899-909[DOI][PubMed]
  • 9. Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P, De Salvia R. Taurine and ellagic acid: two differently-acting natural antioxidants. Environ Mol Mutagen. 1995; 26(3): 248-54[PubMed]
  • 10. Rogerio AP, Fontanari C, Melo MC, Ambrosio SR, de Souza GE, Pereira PS, et al. Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol. 2006; 58(9): 1265-73[DOI][PubMed]
  • 11. Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr. 2008; 99(4): 715-22[DOI][PubMed]
  • 12. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, et al. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials. 2009; 30(27): 4743-51[DOI]
  • 13. Yang CS, Tzou BC, Liu YP, Tsai MJ, Shyue SK, Tzeng SF. Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. J Cell Biochem. 2008; 103(3): 825-34[DOI]
  • 14. Bueno CH, Zangrossi Jr H, Viana MB. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazil J Med Biol Res. 2005; 38(11): 1697-701[DOI]
  • 15. Carlo CN, Stefanacci L, Semendeferi K, Stevens CF. Comparative analyses of the neuron numbers and volumes of the amygdaloid complex in old and new world primates. J Comp Neurol. 2010; 518(8): 1176-98[DOI][PubMed]
  • 16. Pellow S, Chopin P, File SE, Briley M. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985; 14(3): 149-67[DOI]
  • 17. Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology. 2000; 153(3): 365-72[DOI]
  • 18. Archer J. Tests for emotionality in rats and mice: A review. Anim Behav. 1973; 21(2): 205-35[DOI]
  • 19. Galdino PM, Nascimento MV, Sampaio BL, Ferreira RN, Paula JR, Costa EA. Antidepressant-like effect of Lafoensia pacari A. St.-Hil. ethanolic extract and fractions in mice. J Ethnopharmacol. 2009; 124(3): 581-5[DOI][PubMed]
  • 20. Wang Q, Han Y, Xue H. Ligands of the GABAA Receptor Benzodiazepine Binding Site. CNS Drug Rev. 2006; 5(2): 125-44[DOI]
  • 21. Marder M, Paladini AC. GABA(A)-receptor ligands of flavonoid structure. Curr Top Med Chem. 2002; 2(8): 853-67[PubMed]
  • 22. Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA, Paladini AC, et al. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol. 2006; 539(3): 168-76[DOI][PubMed]
  • 23. Hall BJ, Chebib M, Hanrahan JR, Johnston GA. 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes. Eur J Pharmacol. 2005; 512(2-3): 97-104[DOI][PubMed]
  • 24. Girish C, Pradhan SC. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol. 2008; 22(6): 623-32[DOI][PubMed]
  • 25. Girish C, Raj V, Arya J, Balakrishnan S. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 2012; 682(1-3): 118-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments